drugset / Trial / NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
Timeline
- Start
- 2025-07-21
- Primary completion
- 2028-09-11
- Completion
- 2029-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | KarX-EC | Unknown | — | — |
| Comparator | Trospium | Small molecule | — | — |